Dean Investment Associates LLC Sells 220 Shares of MetLife, Inc. (NYSE:MET)

Dean Investment Associates LLC lowered its stake in MetLife, Inc. (NYSE:METFree Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,482 shares of the financial services provider’s stock after selling 220 shares during the quarter. Dean Investment Associates LLC’s holdings in MetLife were worth $367,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Anchor Investment Management LLC increased its stake in shares of MetLife by 12.5% in the 3rd quarter. Anchor Investment Management LLC now owns 6,115 shares of the financial services provider’s stock worth $504,000 after purchasing an additional 681 shares in the last quarter. World Investment Advisors LLC purchased a new stake in shares of MetLife during the third quarter worth about $336,000. Wilmington Savings Fund Society FSB purchased a new position in MetLife in the 3rd quarter worth approximately $701,000. Tidal Investments LLC boosted its position in shares of MetLife by 3.9% during the third quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider’s stock worth $1,590,000 after acquiring an additional 718 shares during the last quarter. Finally, Synovus Financial Corp grew its position in shares of MetLife by 5.5% during the third quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider’s stock valued at $1,874,000 after purchasing an additional 1,183 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

MetLife stock opened at $72.49 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $49.38 billion, a PE ratio of 12.14, a P/E/G ratio of 0.65 and a beta of 0.89. The company has a 50 day moving average price of $79.41 and a 200-day moving average price of $82.19. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05.

MetLife (NYSE:METGet Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on MET. Cowen restated a “buy” rating on shares of MetLife in a research report on Friday, March 7th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Morgan Stanley dropped their target price on MetLife from $109.00 to $94.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. Wells Fargo & Company lowered their price target on MetLife from $97.00 to $91.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Finally, UBS Group boosted their price objective on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $92.46.

Read Our Latest Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.